Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Singapore–Shanghai Medical Innovation Centre (SSMIC) is a strategic collaborative hub established to facilitate cross-border innovation and market entry for healthcare and life sciences companies between Singapore and China. Launched in 2024 under the auspices of the Shanghai-Singapore Comprehensive Cooperation Council (SSCCC), the center is situated in the Lingang Special Area of the Shanghai Pilot Free Trade Zone. It serves as a landing pad for Singaporean medtech and biotech firms, providing them with regulatory guidance, clinical trial support, and access to the Chinese manufacturing ecosystem. Conversely, the center assists Chinese enterprises in leveraging Singapore as a gateway to Southeast Asian markets. SSMIC is a joint initiative supported by Enterprise Singapore and the Shanghai Lingang Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singapore–Shanghai Medical Innovation Centre.